Back to calendar
REGENXBIO Inc. (RGNX) Earnings
RGNX reports earnings on Wednesday, August 5, 2026
earnings report
August 5, 2026 · Before Market Open
Q2 2026
Est. EPS: $0.22
Actual EPS: $-1.72
EPS surprise: -28.65%
Company overview
Market Cap$635.4M
PriceUSD 12.29
EPS (TTM)-5.59
52-week high16.19
52-week low5.46
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees371